Hypocarbia Before Surfactant Therapy Appears to Increase Bronchopulmonary Dysplasia Risk in Infants With Respiratory Distress Syndrome

Abstract

Ventilatory management before rescue treatment with artificial surfactant therapy that result in hypocarbia may increase the risk of bronchopulmonary dysplasia. These findings suggest that early ventilatory management should not only provide adequate oxygenation but also limit hyperventilation.